Revenue management solutions are part of McKesson’s comprehensive portfolio of physician solutions designed to reduce time spent on administrative tasks and streamline practice operations. As the source for
Abbott’s test would be able to detect NGAL about two days earlier than the widely used method for the detection of AKI, a serum creatinine blood test. According
Ardea Biosciences said that in the 28-day, randomised, double-blind, placebo-controlled, dose-escalation study, 123 gout patients with hyperuricemia, received 200mg once-daily (qd) RDEA594, 400mg qd RDEA594, 600mg qd RDEA594
Orexigen Therapeutics said that the NDA for Contrave is based on a substantial body of evidence gathered through the Contrave Obesity Research (COR) clinical program, which included over
Cubist Pharma made this decision after reviewing top line efficacy and safety data from the CB-500,929 Phase 2 Conserv 1 and Conserv 2 trials. Cubist Pharma said that
Reportedly, Vivus failed to start the Luramist Phase 3 trial by the outside date of 1 April 2010 that was set by the independent arbitration panel, convened by
The lawsuits relate to the quality and formulation of Oxaliplatin, available in the US under the brand name Eloxatin. The settlement agreements are subject to review by the
In the published study, Gilles Blancho and colleagues from the Institute of Transplantation – Urology – Nephrology (ITUN) in Nantes, France, have demonstrated that Pharming’s rhC1INH prevented AMR
Moexipril HCl is the generic equivalent of Univasc tablets, marketed by Schwarz. The product is indicated for the treatment of patients with hypertension. Reportedly, in March 2010, Glenmark
The complete response letter identifies issues that would have to be addressed before re-submission, including the generation of additional clinical data. ProStrakan plans to meet with the FDA
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.